Research Data for “Spesolimab in the FDA Adverse Event Reporting System: A Disproportionality Analysis”

Published: 25 August 2026| Version 1 | DOI: 10.17632/r6mr33vgtz.1
Contributors:
AHMET UĞUR ATILAN, Niyazi Çetin

Description

This dataset contains research data from a disproportionality analysis of spesolimab-associated adverse events using the FDA Adverse Event Reporting System (FAERS). The dataset includes analytical datasets, signal detection results, comparator analyses, and supporting safety assessments derived from FAERS reports.

Files

Institutions

Categories

Drug Safety, Pharmacovigilance, Disproportionality Analysis

Licence